A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis

Pulmonary aspergillosis (PA), a pulmonary fungal infection caused by <i>Aspergillus</i> spp., is a concern for immunocompromised populations. Despite substantial research efforts, conventional treatments of PA using antifungal agents are associated with limitations such as excessive syst...

Full description

Bibliographic Details
Main Authors: Shen Nam Cheng, Zhi Guang Tan, Manisha Pandey, Teerapol Srichana, Mallikarjuna Rao Pichika, Bapi Gorain, Hira Choudhury
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Pharmaceutics
Subjects:
pulmonary aspergillosis
pulmonary delivery
dry powder inhalers
nebulizer
antifungal agents
nanotechnology
Online Access:https://www.mdpi.com/1999-4923/12/12/1161

Internet

https://www.mdpi.com/1999-4923/12/12/1161

Similar Items